EBEva A. van Breugel

Eva A. van Breugel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eva A. van Breugel has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sensory sensitivity after subarachnoid hemorrhage

    by Eva A. Van Breugel, Joris A. de Graaf, Celine Didderen, Irene Huenges Wajer, Hella Thielen, Johanna M. A. Visser-Meily, Antonia F. Ten Brink

    Subarachnoid hemorrhage (SAH) is a severe type of stroke that typically affects individuals in their productive years, with the peak incidence between 50 and 60 years of age (Al-Khindi et al., 2010...

  • Open Access

    Cognitive Functioning of Low-Grade Glioma Patients with and Without Adjuvant Treatment Before and One Year After Tumor Resection

    by Eva A. van Breugel, Iris J. M. Bras, Maud J. F. Landers, Nathalie Synhaeve, Geert-Jan Rutten, Karin Gehring

    Background/Objectives: For low-grade glioma (LGG) patients, adjuvant treatment (AT) with radiotherapy and chemotherapy may adversely impact cognition. However, existing evidence is limited by methodological heterogeneity and shortcomings. This study explored the cognitive functioning of LGG patients who underwent resection with both radiotherapy and chemotherapy (AT+) or without AT (AT−), from before resection to one year after resection. Methods: We included patients with World Health Organization 2021 grade 2 isocitrate dehydrogenase-mutated glioma who underwent resection between 2011 and 2024. All patients completed a neuropsychological screening battery one week before (T0) and twelve months after resection (T12), measuring reaction time, attention span, information processing speed, working memory, inhibition, cognitive flexibility, and verbal fluency. We compared cognitive performance between AT+ and AT− patients at T0 and T12, as well as trajectories of cognitive functioning, at the group and individual level. Results: We included 60 LGG patients (M age = 38.8 years; 63.3% male). Compared to AT− patients (n = 35), AT+ patients (n = 25) were significantly older, more frequently had tumors that crossed the midline, and reported more depressive symptoms. At T0, no significant cognitive performance differences existed between AT+ and AT− patients, despite lower observed performance in the AT+ group. At T12, AT+ patients performed significantly worse than AT− patients on mean information processing speed, due to an improvement over time in the AT− group. Conclusions: Patients allocated to AT may show limited cognitive recovery of information processing speed up to 12 months after surgery, without pronounced effects on other cognitive functions. These findings can guide future studies into treatment-related cognitive decline of LGG patients.

  • Open Access

    Monitoring of Executive Functions During Awake Glioma Surgery: A Standardized Multicenter Protocol

    by Maud J. F. Landers, Bart Brouwers, Anne M. Weggelaar, Eva van Breugel, Wouter De Baene, Tessa Meijerink, Martine Wilbers, Pierre A. Robe, Martine J. E. van Zandvoort, Eelke M. Bos, et al.

    BACKGROUND AND OBJECTIVES: Currently, there are no standardized clinical mapping protocols for monitoring of executive functions during awake glioma surgery, primarily due to a lack of evidence-based data for cognitive mapping. By aligning procedures and documentation practices across institutions, clinicians can overcome the current fragmentation in the field and iteratively work toward generating reproducible, high-quality Data sets that will better clarify the clinical relevance of white matter pathways involved in executive functions. A previously conducted pilot study led to the development of a standardized monitoring protocol and demonstrated that pooling of data is feasible when surgical teams commit to the study requirements. The primary goal of this multicenter study protocol is to investigate whether using this standardized protocol can identify white matter tracts involved in executive functions. METHODS: In this prospective, clinical observational study, we will continue data collection in 4 neurosurgical departments from the previously conducted pilot study and expand to other hospitals providing neurosurgical care. We aim to include adult patients that will undergo awake primary glioma surgery and undergo monitoring of executive functions with a uniform set of tasks for the following white matter tracts: frontal aslant tract, superior longitudinal fasciculus II and II, arcuate fasciculus, inferior fronto-occipital fasciculus. Data will be collected in a standardized manner for each patient before, during, and after surgery. EXPECTED OUTCOMES: The primary objective of this study was to determine if executive functions can be effectively monitored using a standardized protocol during awake glioma surgery in multiple neurosurgical centers. DISCUSSION: Despite limitations inherent to multicenter and observational studies, this study represents a necessary step toward developing a validated uniform way of collecting intraoperative findings on mapping of executive functions. The generation of high-quality Data sets is highly needed to extend the scientific basis for monitoring of white matter pathways involved in executive functions.


  • Open Access

    Cognitive Performance in Parkinson’s Spectrum Disorders: a comparative study of patients with Parkinson’s Disease, Parkinson’s Disease Dementia, Dementia With Lewy Bodies, Progressive Supranuclear Palsy, and Corticobasal Syndrome

    by Eva A. van Breugel, Esther van Den Berg, Sanne Franzen, Judy van Hemmen, Harro Seelaar, Caroline van Heugten, Lize C. Jiskoot

    The Parkinson’s spectrum encompasses Parkinson’s disease (PD), PD dementia (PDD), dementia with Lewy bodies (DLB), progressive supranuclear palsy (PSP), and corticobasal syndrome (CBS). Clinical diagnosis mainly relies on progression over time and neuroimaging, biomarkers, and neurological observations, aided by neuropsychological assessment. Neuropsychological profiles and differences within the Parkinson’s spectrum have been understudied. This retrospective study analyzed mean performance and proportions of impairment of neuropsychological assessments of 212 patients in the Parkinson’s spectrum at an academic outpatient memory clinic. Patients with PD scored significantly higher than the other patient groups on most tests. The other patient groups showed limited significant differences from one another. The letter fluency test was most effective in distinguishing PD from the other disorders. The auditory verbal learning test was suitable to distinguish PDD and DLB from the other disorders. Results indicate considerable overlap in cognitive profiles across Parkinson’s spectrum disorders, suggesting neuropsychological assessment is valuable for assessing cognitive function, guiding post-diagnostic support, and monitoring progression, rather than differential diagnosis.